Active

Zygote

Switched

BE0773774443

Rechtspersoon Public limited company 1 establishment

Veldkant 33 A, 2550 Kontich Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten 034508030

Active for

4 year, 11 months

Financials

Financial year 2025

Revenue

€ 2.3 million

▲ 118% vs 2024

Profit

Growing

€ 290,684

▲ 233% vs 2024

Debts

Low

€ 420,046

▲ 16% vs 2024

Zygote from Kontich, company number BE0773774443, closed financial year 2025 with a result of € 290,684 after tax. For that financial year Zygote recorded revenue of € 2.3 million and equity of € 294,554. Compared with financial year 2024, the result moved from € -218,995 to € 290,684. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What happened at Zygote?

What happened at Zygote in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • De Cronos Groep stepped down as director. NBB
  • Crosspoint Solutions stepped down as director. NBB
  • Josephus de Wit stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 290,684. Source: NBB ↗
  • New establishment in Kontich. KBO
  • Start of the company according to the CBE. KBO
  • De Cronos Groep became a director. NBB
  • Crosspoint Solutions became a director. NBB

In short

From € 10,017 loss in 2022 to € 290,684 profit in 2025.

Paid € 41,223 in corporate taxes since 2022.

Best year ever: 2025, with € 290,684 profit.

On average € 105,400 of value added per employee in 2025.

A new publication or filing at Zygote? We notify you, reason included.

Follow Zygote

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

The shares are held by Crosspoint Solutions NV (80%). It owns 90% of LabLife itself.

See the full network in the app

Directors

According to the 2025 annual accounts

De Cronos Groep

Director · represented by Dirk Deroost

Owns 80% via Crosspoint Solutions NV

Also active at: RESIDENCE LES ONDES, FOCUS ADVERTISING, Cronos +449 more

since 2021 · until 2027

Crosspoint Solutions

Director · represented by Ans Anthonis

since 2021 · until 2027

Josephus de Wit

Director

since 2021 · until 2027

Shareholders

Crosspoint Solutions NV · holding of De Cronos Groep

80%

Participations

Establishments

Establishment units

Physical locations of this company

Registered office

Veldkant 33 A

2550 Kontich

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0773.774.443
VAT number
BE 0773.774.443
Registered office
Veldkant 33 A, 2550 Kontich
Names & denominations
Zygote
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
13 September 2021
Peppol
Active · Active since 1 Jan 2001
Contact
034508030
Activities · NACE

Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten

Computerconsultancy-activiteiten

Frequently asked questions

What is the enterprise number of Zygote?
The enterprise number of Zygote is BE0773774443.
What is the address of Zygote?
The registered office of Zygote is located at Veldkant 33 A, 2550 Kontich.
When was Zygote founded?
Zygote was founded on 13 September 2021.
What is the main activity of Zygote?
The main activity of Zygote is "Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten" (NACE code 62200).
Does Zygote have a website?
No website is currently known for Zygote.
How much profit did Zygote make in 2025?
Zygote posted a profit after taxes of € 290,684 in financial year 2025.
What is the revenue of Zygote?
In its most recent annual accounts (2025), Zygote reported revenue of € 2,330,017.
How many employees does Zygote have?
According to the 2025 annual accounts, Zygote has 15.4 full-time equivalents (FTE).
Where can I find the annual accounts of Zygote?
Zygote files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Zygote?
According to the 2025 annual accounts, the directors of Zygote are: De Cronos Groep, Crosspoint Solutions, Josephus de Wit.
Who owns Zygote?
The shares are held by Crosspoint Solutions NV (80%). It owns 90% of LabLife itself.
Who are the shareholders of Zygote?
According to the 2025 annual accounts, the shareholders of Zygote are: Crosspoint Solutions NV (80%).